Estropipate
From Self-sufficiency
Revision as of 23:50, 22 February 2010 by Belovedfreak (Talk) (Disambiguate Hormone replacement therapy to Hormone replacement therapy (menopause) using popups)
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (June 2009) |
| File:Estropipate.png | |
| Systematic (IUPAC) name | |
|---|---|
|
[(8R,9S,13S,14S)-13-Methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate; piperazine | |
| Identifiers | |
| CAS Number | 7280-37-7 |
| ATC code | none |
| PubChem | CID 5284555 |
| Chemical data | |
| Formula | C22H32N2O5S |
| Molar mass | 436.56 g/mol[[Script error: No such module "String".]] |
Estropipate is a form of estrogen sold under the brand names Ogen and Ortho-Est. It is a salt of estrone sulfate and piperazine.
Uses
Estropipate is used to:
- Alleviate symptoms of menopause as hormone replacement therapy
- Treat some types of infertility
- Treat some conditions leading to underdevelopment of female sexual characteristics
- Treat vaginal atrophy
- Treat some types of breast cancer (particularly in men and postmenopausal women)
- Treat prostate cancer
- Prevent osteoporosis
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from June 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Missing redirects
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Estrogens
- Pharmacology stubs
- 2Fix
